alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Official Journal C 313/2022

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 313 |
| | |
| English edition | Information and Notices | Volume 6517 August 2022 |

ISSN 1977-091X

Official Journal

of the European Union

C 313

English edition

Information and Notices

Volume 6517 August 2022

---

| Contents | page |
| --- | --- |
| | IV   Notices |
| | NOTICES FROM MEMBER STATES |
| 2022/C 313/01 | List of the bilateral investment agreements referred to in Article 4(1) of Regulation (EU) No 1219/2012 of the European Parliament and of the Council establishing transitional arrangements for bilateral investment agreements between Member States and third countries | 1 |

Contents

page

IV   Notices

NOTICES FROM MEMBER STATES

2022/C 313/01

List of the bilateral investment agreements referred to in Article 4(1) of Regulation (EU) No 1219/2012 of the European Parliament and of the Council establishing transitional arrangements for bilateral investment agreements between Member States and third countries

1

---

| EN | |
| --- | --- |

EN
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Energy Federal Energy Regulatory Commission
 Project No.Northern Indiana Public Service Company
12514-084Northern Indiana Public Service Company LLC
 On January 3, 2018, Northern Indiana Public Service Company (transferor) and Northern Indiana Public Service Company LLC (transferee) filed an application for the transfer of license of the Norway-Oakdale Hydroelectric Project No. 12514. The project is located on the Tippecanoe River in Carroll and White counties, Indiana. The applicants seek Commission approval to transfer the license for the Norway-Oakdale Hydroelectric Project from the transferor to the transferee. This transfer of license reflects an internal corporate reorganization. The transferor will be merged into newly created transferee. *Applicants Contact:*
                     Ms. Hallie Meushaw, Troutman Sanders LLP, 600 Peachtree Street NE, Suite 5200, Atlanta, GA 30308, Phone: 404-885-3660, Email: 
                    *hallie.meushaw@troutman.com*
                     and Mr. M. Bryan Little, Senior Counsel, NiSource Corporate Services, 150 West Market Street, Ste. 600, Indianapolis, IN 46204, Phone: 317-694-4903, Email: 
                    *Blittle@nisource.com.* *FERC Contact:*
                     Patricia W. Gillis, (202) 502-8735, 
                    *patricia.gillis@ferc.gov.* *Deadline for filing comments, motions to intervene, and protests:*
                     30 days from the date that the Commission issues this notice. The Commission strongly encourages electronic filing. Please file comments, motions to intervene, and protests using the Commission's eFiling system at 
                    *http://www.ferc.gov/​docs-filing/​efiling.asp.*
                     Commenters can submit brief comments up to 6,000 characters, without prior registration, using the eComment system at 
                    *http://www.ferc.gov/​docs-filing/​ecomment.asp.*
                     You must include your name and contact information at the end of your comments. For assistance, please contact FERC Online Support at 
                    *FERCOnlineSupport@ferc.gov,*
                     (866) 208-3676 (toll free), or (202) 502-8659 (TTY). In lieu of electronic filing, please send a paper copy to: Secretary, Federal Energy Regulatory Commission, 888 First Street NE, Washington, DC 20426. The first page of any filing should include docket number P-12514-084. Dated: January 18, 2018. Kimberly D. Bose, Secretary.


[FR Doc. 2018-01230 Filed 1-23-18; 8:45 am] BILLING CODE 6717-01-P
C.J.G., Appellant, v. STATE of Florida, Appellee.

No. 1D16-5528

District Court of Appeal of Florida, First District.

March 29, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Richard MARGAREJO, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D17-2512

District Court of Appeal of Florida, Second District.

August 16, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Writ of mandamus is denied.
**EXHIBIT 32.1**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO SECTION 906OF**

**THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theQuarterly Report of Magnetek, Inc. (the “Company”) on Form 10-Q forthe period ending January 1, 2006 as filed with the Securities andExchange Commission on the date hereof (the “Report”), the undersigned, ThomasG. Boren, President and Chief Executive Officer of the Company, and David P.Reiland, Executive Vice President and Chief Financial Officer of the Company,hereby certify, pursuant to U.S.C. Section 1350 and Rule 13a-14(b) orRule 15d-14(b) of the Securities Exchange Act of 1934, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)            the Report fully complies with the requirementsof Section 13(a) or 15(d) of the Securities Exchange Act of1934; and

 

(2)            the information contained in theReport fairly presents, in all material respects, the financial condition andresults of operations of the Company.

 

 
|                           | /s/  Thomas  G. Boren |   |
|--------------------------------|----------------------------|--------|
|                           | Thomas G. Boren            |
|                           | President and              |
|                           | Chief Executive  Officer   |
|                           |                       |
| /s/  David  P. Reiland    |                       |   |
| David P. Reiland               |                       |
| Executive Vice-President  and  |                       |
| Chief Financial Officer        |                       |
|                           |                       |
|                           |                       |
| Dated:  February 10, 2006 |                       |
|                                |                            |        |  |

 

1

----
<PAGE>

                                  EXHIBIT 32.1



             CERTIFICATION OF PRINCIPAL EXECUTIVE FINANCIAL OFFICER
                       AND THE PRINCIPAL FINANCIAL OFFICER


I, Christine Koenemann, Principal Executive Officer and Principal Financial
Officer of Westbridge Research Group (the "Registrant"), does hereby certify in
accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  the quarterly report on Form 10-QSB of the Registrant, to which this
          certificate is attached as an exhibit (the "Report"), fully complies
          with the requirements of Section 13(a) or 15(d) of the Securities
          Exchange Act of 1934 (15 U.S.C. 78m), as amended; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Registrant.


October 14, 2005           /s/ Christine Koenemann
                           --------------------------------------------
                           Principal Executive Officer and Principal
                           Financial Officer
Exhibit 10.79

 

AMENDMENT #8

 

To Letter of Intent for Proposed CRADA #02166

 

“Preclinical and Clinical Development of 1-Methyl-[d]-Tryptophan as an

Anti-Cancer Agent”

 

The purpose of this amendment is to change certain terms of the Letter of Intent (LOI) for the proposed Cooperative Research and Development Agreement (CRADA) entitled “Preclinical and Clinical Development of 1-Methyl-[d]-Tryptophan as an Anti-Cancer Agent”.  These changes are reflected below, and except for these changes, all other provisions of the original CRADA LOI remain in full force and effect. Two originals of this amendment are provided for execution; one is to remain with the National Cancer Institute (NCI) and the other copy is to remain with the Collaborator.

 

Upon final signature, the term of the CRADA Letter of Intent is retroactively extended for one year from May 23, 2011 to, May 23, 2012.

 

 

	
AGREED AND ACCEPTED:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
For the National Cancer Instute:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/ Douglas R. Lowy, M.D.
    	
 
    	
5/26/2011
    
	
Douglas R. Lowy, M.D.
    	
 
    	
Date
    
	
Deputy Director, NCI
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
For NewLink Genetics Corporation:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/ Nicholas Vahanian, M.D.
    	
 
    	
6/2/2011
    
	
Nicholas Vahanian, M.D.
    	
 
    	
Date
    
	
Chief Operating Officer
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, June 14, 2018.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, June 14, 2018

The Court of Appeals hereby passes the following order

A18D0479. IN THE INTEREST OF L. B. F., et al., CHILDREN (MOTHER).

Upon consideration of the Application for Discretionary Appeal, it is ordered that it be 

hereby DENIED.

LC NUMBERS:

18JV000070
#### UNITED STATES of America, Plaintiff-Appellee, v. Matilda BONILLA, Defendant-Appellant.

No. 03-20806.

Summary Calendar

United States Court' of Appeals, Fifth Circuit.

DECIDED: May 24, 2004.

Paula Camille Offenhauser, Assistant US Attorney, James Lee Turner, Assistant US Attorney, Houston, TX, for PlaintiffAppellee.

Ali Fazel, Scardino, Courtney & Fazel, Houston, TX, for Defendant-Appellant.

*503Before BARKSDALE, EMILIO M. GARZA, and DENNIS, Circuit Judges.

PER CURIAM:*

Matilda Bonilla appeals her sentence following her conviction for failure to appear for trial to face a 1991 indictment charging her with drug offenses. She argues that the district court erred in upwardly departing pursuant to U.S.S.G. § 5K2.21 for conduct allegedly already accounted for under U.S.S.G. § 2J1.6(b)(2)(A). Bonilla did not object to the upward departure on the basis now argued on appeal; therefore, our review is for plain error only. *See United States v. Vasquez,*216 F.3d 456, 459 (5th Cir.2000).

Bonilla’s double-counting argument fails because the district court based its upward departure on the conduct underlying the dismissed charge, *i.e.,*her drug activity and the fact that she successfully evaded prosecution, factors that did not enter into the determination of the applicable guideline range under § 2J1.6. *See*U.S.S.G. § 2J1.6 (2002), comment, (backg’d); *United States v. Harper,*932 F.2d 1073, 1077 (5th Cir.1991).

We also reject Bonilla’s alternative argument that the evidence was insufficient to justify an upward departure. First, Bonilla’s contention that her actions had no bearing on the Government’s decision to dismiss the 1991 indictment is meritless given that her status as a fugitive for nearly eleven years directly caused the evidence against her to become stale. Second, absent any rebuttal evidence from Bonilla at sentencing, the district court was entitled to rely on the findings in the presentence report concerning the charged drug offenses. *See United States v. Huerta,*182 F.3d 361, 364-65 (5th Cir.1999).

AFFIRMED.

*

 Pursuant to *5th Cir. R. 47.5, the*court has determined that this opinion should, not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
118TH CONGRESS 

2D SESSION S. 1059 

AN ACT 

To adjust the boundary of Big Bend National Park in the 

State of Texas, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

†S 1059 ES

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Big Bend National 

3 Park Boundary Adjustment Act’’. 

4 SEC. 2. DEFINITIONS. 

5 In this Act: 

6 (1) MAP.—The term ‘‘map’’ means the map en7 titled ‘‘Big Bend National Park, Proposed Boundary 

8 Adjustment’’, numbered 155/167,296, and dated 

9 November 2022. 

10 (2) PARK.—The term ‘‘Park’’ means the Big 

11 Bend National Park established under the Act of 

12 June 20, 1935 (49 Stat. 393, chapter 283; 16 

13 U.S.C. 156). 

14 (3) SECRETARY.—The term ‘‘Secretary’’ means 

15 the Secretary of the Interior. 

16 SEC. 3. BIG BEND NATIONAL PARK BOUNDARY ADJUST17 MENT. 

18 (a) LAND ACQUISITION.—The Secretary may acquire 

19 approximately 6,100 acres of land or interests in land gen20 erally depicted on the map as ‘‘Tracts to Include in 

21 Boundary’’ by donation, purchase from willing sellers, or 

22 exchange. 

23 (b) AVAILABILITY OF MAP.—The map shall be on file 

24 and available for public inspection in the appropriate of25 fices of the National Park Service. 
3 

†S 1059 ES

1 (c) BOUNDARY REVISION AND ADMINISTRATION.— 

2 On acquisition of any land or interests in land under sub3 section (a), the Secretary shall— 

4 (1) revise the boundary of the Park to include 

5 the acquired land or interests in land; and 

6 (2) administer the acquired land or interests in 

7 land as part of the Park in accordance with applica8 ble laws (including regulations). 

9 (d) EMINENT DOMAIN OR CONDEMNATION.—In car10 rying out this Act, the Secretary may not use eminent do11 main or condemnation. 

Passed the Senate December 18 (legislative day, December 16), 2024. 

Attest: 

Secretary. 
118TH CONGRESS 

2D SESSION S. 1059 

AN ACT 

To adjust the boundary of Big Bend National Park 

in the State of Texas, and for other purposes.
Exhibit 32.2





CERTIFICATIONS PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


(18 U.S.C. SECTION 1350)





In connection with the annual report of Empirical Ventures Inc. (the "Company") on Form 10-K for the period ending June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Anthony Jackson, Chief Financial Officer, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and





(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





Date: February 21, 2014
By:
/s/ Anthony JacksonName:
Anthony JacksonTitle:
Chief Financial Officer (Principal Accounting Officer)
Exhibit 32.2
 Certification of the Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
 (2)
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
 Date: February 18, 2011
    By:
    /s/ Robert D. StilesRobert D. StilesChief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer) 
 *
    
    The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and
is not being filed as part of the Report or as a separate disclosure document.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Davidson
Diversified Real Estate II, L.P. 1997 First Quarter 10-QSB and is qualified in
its entirety by reference to such 10-QSB filing.
</LEGEND>
<CIK> 0000750258
<NAME> DAVIDSON DIVERSIFIED REAL ESTATE II, L.P.
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                           1,042
<SECURITIES>                                         0
<RECEIVABLES>                                      106
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                          43,903
<DEPRECIATION>                                (19,911)
<TOTAL-ASSETS>                                  26,738
<CURRENT-LIABILITIES>                                0
<BONDS>                                         26,541
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                       (979)
<TOTAL-LIABILITY-AND-EQUITY>                    26,738
<SALES>                                              0
<TOTAL-REVENUES>                                 2,234
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 2,369
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 619
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (135)
<EPS-PRIMARY>                                 (107.51)<F1>
<EPS-DILUTED>                                        0
<FN>
<F1>Multiplier is 1.
</FN>
        

</TABLE>
----

**Exhibit 32.1**

** **

** **

**CERTIFICATE OF PRINCIPALEXECUTIVE OFFICER PURSUANT TO**

**18 U.S.C. SECTION1350, AS ENACTED PURSUANT TO**

**SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**

 

 

In connection with the QuarterlyReport of Seitel, Inc. ("the Company") on Form 10-Q for the quarter ended June30, 2007 as filedwith the Securities and Exchange Commission on the date hereof (the"Report"), I, Robert D. Monson, President and Principal ExecutiveOfficer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of myknowledge and belief, that:

 
| (1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | The Report fully complies with  the requirements of section 13(a) or 15(d) of the Securities Exchange Act of  1934; and

  |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------|
| (2)

The information contained in  the Report fairly presents, in all material respects, the financial condition  and results of operations of the Company.

 

Date: September 4, 2007

  /s/ Robert D. Monson

Robert D. Monson

President and Principal Executive Officer

 

A signed original of this writtenstatement, required by Section 906, has been provided to the Company and willbe furnished to the Securities and Exchange Commission or its staff uponrequest.

  |
Exhibit 12.2

CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kaare G. Foy, Chairman and Chief Financial Officer of Great Panther Resources Limited, certify that:

1. I have reviewed this annual report on Form 20-F of Great Panther Resources Limited;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

4. The company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by this annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and

5. The company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.

Date: July 14, 2005

/s/ Kaare G. FoyKaare G. Foy
Chairman and Chief Financial Officer